CIMS Unveils Dynamic Data Monitoring and Dynamic Trial Design at SCOPE 2019

[vc_row][vc_column][vc_column_text css=”.vc_custom_1555864818027{margin-bottom: 0px !important;}”]CIMS is proud to introduce its AI-engineered statistical package and full suite of eClinical offerings at SCOPE 2019 in Orlando.

Called Dynamic Data Monitoring (DDM), this one-of-a-kind, patented DDM platform utilizes machine learning and artificial intelligence to dynamically monitor and optimize your clinical trial. With the CIMS closed system, you can typically determine if your drug is working, or failing, in half of the time of the current standard.

Here’s how DDM is reshaping the future of clinical trials:[/vc_column_text][vc_column_text css=”.vc_custom_1555864780530{margin-bottom: 0px !important;}”]

Trial optimization

  • Optimize your on-going trial to maximize its success

Early termination of “hopeless” trials

  • Receive alerts to conduct a formal futility analysis, enrich your population or modify your sample size
  • Timely terminate a “hopeless” trial

Drug safety detection

  • Continue monitoring drug safety and signal detection

Dose selection

  • Optimize a phase 2/3 combination trial by identifying potential doses for phase 3

Population selection

  • Intelligently identify the most effective subpopulation
  • Apply to an RCT (Randomized controlled trial) or RWE (Real World Evidence) setting for personalized medicine

Sample size re-estimation

  • Intelligently estimate an optimal sample size to maximize the probability of success

Model checking and correction

  • Check and verify the assumptions set prior to the initiation of the trial
  • Implement corrections as the trial moves forward

The CIMS DDM is backed by published research. Visit us at booth 36 or contact us.

About CIMS

CIMS is pioneering the DTD and DDM categories with a vision of reshaping the future of clinical trials. With our proprietary closed system, we’re empowering pharmaceutical and biotech companies to bring drugs to market sooner, saving millions of dollars on clinical trials and bringing much-needed therapies to patients faster.[/vc_column_text][/vc_column][/vc_row]






Leave a Reply

Your email address will not be published. Required fields are marked *